We are live on !
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$156M
Turnover
90.24%
1-Year Est. Return
14.89%
This Fund
S&P 500
This Quarter Est. Return
+7.46%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.1%
AUM
$156M
AUM Growth
+$74.4M
(+91%)
Cap. Flow
+$78.8M
Cap. Flow % of AUM
Cap. Flow %
50.43%
Top 10 Holdings %
Top 10 Hldgs %
25.26%
Holding
328
New
191
Increased
20
Reduced
12
Closed
105
Avg Time Held
0
years
Top 10 Avg Time Held
0.1
years
Top 20 Avg Time Held
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$8.52M |
| 2 |
NVIDIA
NVDA
|
+$6.41M |
| 3 |
Oracle
ORCL
|
+$5.76M |
| 4 |
Microsoft
MSFT
|
+$3.56M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$3.44M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sandisk
SNDK
|
+$5.33M |
| 2 |
ExxonMobil
XOM
|
+$2.87M |
| 3 |
Meta Platforms (Facebook)
META
|
+$2.69M |
| 4 |
Rocket Lab Corp
RKLB
|
+$2.61M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$2.54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.57% |
| 2 | Consumer Discretionary | 16.88% |
| 3 | Financials | 11.54% |
| 4 | Healthcare | 9.13% |
| 5 | Materials | 6.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Church & Dwight Co
CHD
$25B
| $434K | 0.28% |
+4,479
| New | +$428K |
2026 Q2
0 quarters
|
|
102
Jefferies Financial Group
JEF
$10.3B
| $430K | 0.27% |
+8,600
| New | +$443K |
2026 Q2
0 quarters
|
|
103
Akamai
AKAM
$13.4B
| $430K | 0.27% |
+3,636
| New | +$453K |
2026 Q2
0 quarters
|
|
104
Kroger
KR
$39.4B
| $428K | 0.27% |
+7,700
| New | +$502K |
2026 Q2
0 quarters
|
|
105
Amer Sports
AS
$16.4B
| $423K | 0.27% |
+12,509
| New | +$438K |
2026 Q2
0 quarters
|
|
106
Trade Desk
TTD
$6.15B
| $423K | 0.27% |
23,400
+1,800
| +8% | +$38.2K |
2025 Q4
2 quarters
|
|
107
Constellation Energy
CEG
$89.8B
| $422K | 0.27% |
+1,700
| New | +$479K |
2026 Q2
0 quarters
|
|
108
Nutrien
NTR
$33.3B
| $422K | 0.27% |
+6,700
| New | +$469K |
2026 Q2
0 quarters
|
|
109
Novo Nordisk
NVO
$172B
| $407K | 0.26% |
8,500
-20,100
| -70% | -$864K |
2026 Q1
1 quarter
|
|
110
Skyworks Solutions
SWKS
$19.6B
| $407K | 0.26% |
+6,000
| New | +$408K |
2026 Q2
0 quarters
|
|
111
Skydance Corporation
SKYD
$39.2B
| $402K | 0.26% |
+40,800
| New | +$429K |
2026 Q2
0 quarters
|
|
112
UiPath
PATH
$7.36B
| $401K | 0.26% |
+36,900
| New | +$394K |
2026 Q2
0 quarters
|
|
113
Idexx Laboratories
IDXX
$44.1B
| $394K | 0.25% |
+749
| New | +$420K |
2026 Q2
0 quarters
|
|
114
Coeur Mining
CDE
$13.8B
| $393K | 0.25% |
24,100
+4,774
| +25% | +$87K |
2026 Q1
1 quarter
|
|
115
GameStop
GME
$12.5B
| $386K | 0.25% |
17,500
-12,500
| -42% | -$287K |
2026 Q1
1 quarter
|
|
116
Broadcom
AVGO
$1.54T
| $378K | 0.24% |
1,000
-200
| -17% | -$80.2K |
2026 Q1
1 quarter
|
|
117
iShares Core S&P 500 ETF
IVV
$876B
| $374K | 0.24% |
+500
| New | +$364K |
2026 Q2
0 quarters
|
|
118
Zoom
ZM
$27.9B
| $371K | 0.24% |
+4,300
| New | +$406K |
2026 Q2
0 quarters
|
|
119
Novartis
NVS
$287B
| $371K | 0.24% |
+2,365
| New | +$355K |
2026 Q2
0 quarters
|
|
120
ING
ING
$90.5B
| $370K | 0.24% |
+11,800
| New | +$349K |
2026 Q2
0 quarters
|
|
121
Comfort Systems
FIX
$40.9B
| $369K | 0.24% |
+186
| New | +$338K |
2026 Q2
0 quarters
|
|
122
Seagate
STX
$143B
| $367K | 0.23% |
+380
| New | +$290K |
2026 Q2
0 quarters
|
|
123
Symbotic
SYM
$5.1B
| $366K | 0.23% |
+8,149
| New | +$415K |
2026 Q2
0 quarters
|
|
124
Sensata Technologies
ST
$5.88B
| $366K | 0.23% |
+7,666
| New | +$347K |
2026 Q2
0 quarters
|
|
125
Dropbox
DBX
$8.23B
| $365K | 0.23% |
+13,287
| New | +$341K |
2026 Q2
0 quarters
|
|
Similar funds
HSM
APW
Bayesian Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Bayesian Capital Management held 328 positions worth $156M, up 91% from $81.9M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Bayesian Capital Management deployed $78.8M of net new capital in Q2 2026, opening 191 new positions and adding to 20 existing holdings. Its largest new stake was Alibaba: 67,999 shares worth $6.53M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Sandisk, an estimated $5.33M trimmed.
- Bayesian Capital Management's largest Q2 2026 buy was Alibaba: 67,999 shares worth $6.53M.
- Bayesian Capital Management added most to Oracle in Q2 2026, an estimated $5.76M increase.
- Bayesian Capital Management's biggest Q2 2026 reduction was Sandisk, cutting an estimated $5.33M.
- Bayesian Capital Management fully exited ExxonMobil in Q2 2026, selling an estimated $2.87M.
- Bayesian Capital Management's ten largest holdings make up 25% of its $156M portfolio in Q2 2026.
- Bayesian Capital Management opened 191 new positions and closed 105 in Q2 2026.
- Bayesian Capital Management's portfolio value rose 91% quarter-over-quarter to $156M.
Based on Bayesian Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.